Henrich TJ, Schreiner C, Cameron C, Hogan LE, Richardson B, Rutishauser RL, Deitchman AN, Chu S, Rogers R, Thanh C, Gibson EA, Zarinsefat A, Bakkour S, Aweeka F, Busch MP, Liegler T, Baker C, Milush J, Deeks SG, Stock PG. Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study. Am J Transplant. 2020 Aug 11.
Publications
2023 |
2022 |
2021 |
2021 |
2021 |
Shared Mechanisms Govern HIV Transcriptional Suppression in Circulating CD103+ and Gut CD4+ T Cells.
2020 |
2020 |
2020 |
2020 |
2020 |
2020 |
2020 |
2019 |
2019 |
2019 |
2019 |
2019 |
2019 |
2019 |
2018 |
- 1 of 8
- next ›